The treatment, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), works by blocking specific hormones that contribute to endometriosis, while also ...

NICE guidance published today recommends leniolisib (also called Joenja and made by Pharming) for treating activated phosphoinositide 3-kinase delta syndrome (APDS) in people 12 years and over.

Our highly specialised technologies (HST) programme is designed specifically to evaluate technologies for ultra-rare, debilitating conditions. It helps encourage research and innovation in areas where ...

To declare any new board interests and executive team interests, and consider any conflicts of interest specific to the meeting. Minutes of the last board meeting (Word) To approve the minutes of the ...

more consistent monitoring across healthcare settings. Our draft quality standard, published today for consultation, aims to identify people at risk of weight-related complications earlier so they can ...

The National Institute for Health and Care Excellence (NICE) is producing late-stage assessment guidance on Intermittent urethral catheters for chronic incomplete bladder emptying in adults: ...

Suggested remit: To appraise the clinical and cost effectiveness of daratumumab with bortezomib, lenalidomide and dexamethasone within its marketing authorisation for untreated multiple myeloma when ...

A list of downloadable documents created during development.

A list of downloadable documents created during development.